All Stories

  1. Clinical relevance of genetic variants in the von Willebrand factor according to in‐silico methods
  2. From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease
  3. Comparación de perfiles multiméricos del factor de von Willebrand obtenidos mediante un ensayo electroforético comercial y electroforesis local con geles de agarosa 1%
  4. Von Willebrand disease type 2M: Correlation between genotype and phenotype: Comment from Woods et al.
  5. Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms
  6. Not always genotypic variants causing VWD2N are recessive
  7. Combined effects of two mutations in von Willebrand disease 2M phenotype
  8. Type 2B von Willebrand disease, diagnosis
  9. PT-VWD posing diagnostic and therapeutic challenges – small case series
  10. Identification of p.W246L As a Novel Mutation in the GP1BA Gene Responsible for Platelet-Type von Willebrand Disease
  11. Clinical profile of the association of P.R1205h and P.R924q in a patient with von Willebrand's disease
  12. von Willebrand disease in a single institution in Argentina, December 2017
  13. Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis
  14. A new ADAMTS13 missense mutation (D1362V) in thrombotic thrombocytopenic purpura diagnosed during pregnancy
  15. Diagnosis and Management of von Willebrand Disease in a Single Institution of Argentina
  16. Diagnosis and Management ofvon Willebrand Disease in a Single Institution of Argentina
  17. C1272F: a novel type 2A von Willebrand’s disease mutation in A1 domain; its clinical significance
  18. von Willebrand’s disease diagnosis and laboratory issues
  19. Biological and clinical response to desmopressin (DDAVP) in a retrospective cohort study of children with low von Willebrand factor levels and bleeding history
  20. Major haemorrhage related to surgery in patients with type 1 and possible type 1 von Willebrand disease
  21. Evaluation of the clinical safety of desmopressin during pregnancy in women with a low plasmatic von Willebrand factor level and bleeding history
  22. R924Q substitution encoded within exon 21 of the von Willebrand Factor gene related to mild bleeding phenotype
  23. von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women
  24. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium
  25. Control of von Willebrand factor multimer size by a fibronectin-related substance
  26. IONIZING RADIATION INCREASES CONCENTRATION OF PLASMA VON WILLEBRAND FACTOR IN CEBUS APELLA PARAGUAYANUS MONKEYS
  27. The inhibitory effect of platelets on fibrinolysis in diabetic patients
  28. Congenital factor XIII deficiency associated with von willebrand disease
  29. The effect of venous occlusion on the PAI and antiplasmins release from platelets
  30. Visualization of the multimeric structure of von Willebrand factor by immunoenzymatic stain using avidin-peroxidase complex instead of avidin-biotin peroxidase complex
  31. Aspirin effect on the release of plasminogen activators inhibitors by human platelets
  32. Intraplatelet levels of VWF: AG and fibrinogen in myeloproliferative disorders
  33. Aspirin effect on platelet antiplasmins release
  34. Antithrombotic therapy in children and adolescents